Supernova Invest
  • Home
  • About us
  • Portfolio
  • Submit a project
  • Newsroom
    • Media
  • Contact us
  • EN
  • FR
Select Page
BIOCORP and Diabeloop announce co-development agreement in personalized diabetes management.

BIOCORP and Diabeloop announce co-development agreement in personalized diabetes management.

by alexis | Mar 22, 2021 | Non classé

Integration of automated solutions into the insulin smart pen market BIOCORP, a French company specialized in the development and manufacturing of medical devices and connected solutions in the health sector and Diabeloop, a young company, pioneer in therapeutic...
BIOCORP and Diabeloop announce co-development agreement in personalized diabetes management.

Diabeloop integrates the Accu-Chek Insight insulin pump from Roche into its Automated Insulin Delivery System

by alexis | Mar 1, 2021 | Non classé

The French company Diabeloop announced today it has integrated the Accu-Chek Insight insulin pump from diabetes care leader Roche into its DBLG1 System. The automated and personalized solution for Type 1 diabetes management will be available in select European...

Recent Posts

  • Maddyness – What funds do: Supernova Invest’ profile
  • CrowdSec wants to become the “Waze” of cybersecurity
  • The French CrowdSec attempts a collaborative cyber protection
  • Why French Tech can win the battle of the quantum computer
  • ProovStation raises €10.4 million, continues to scan for damage

Recent Comments

    Archives

    • February 2023
    • November 2022
    • September 2022
    • June 2022
    • May 2022
    • April 2022
    • March 2022
    • February 2022
    • January 2022
    • December 2021
    • October 2021
    • September 2021
    • July 2021
    • May 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • December 2020
    • October 2017
    • September 2017

    Categories

    • Medias
    • News
    • Non classé

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • Facebook
    • Twitter
    • Instagram
    • RSS

    Designed by Elegant Themes | Powered by WordPress